Flere ramt af hukommelsessygdomme i aldrende samfund

Dansk

Jo ældre befolkningen bliver, desto flere rammes af hukommelsessygdomme som Alzheimers. Forskningen inden for området skrider dog langsomt frem, og kun omkring halvdelen af de ramte modtager den tilgængelige behandling.

I et debatindlæg i Dagens Nyheter stiller Lisa Magnusson spørgsmålstegn ved, hvor behagelige de sidste leveår virkelig vil blive for mange ældre mennesker. Hun påpeker, at jo længere levetid, desto flere individer rammes af hukommelsessygdomme. På trods af dette skrider forskningen på området langsomt frem.nnnIndlægget slår fast, at kun omkring halvdelen af dem, der lider af Alzheimers, modtager den behandling, der faktisk er tilgængelig. Dette vækker bekymring for, hvordan samfundet møder den stigende udbredelse af disse tilstande. Magnusson fremhæver behovet for bedre støtte og fremskridt inden for sundhedsvæsenet for at sikre en værdig alderdom.nnnStykket blev offentliggjort den 10. januar 2026 og er en del af DN's lederside, der fokuserer på debat og refleksion over samfundsspørgsmål.

Relaterede artikler

Diverse young adults reviewing charts on rising cognitive disabilities in a community setting, illustrating a Neurology study on surges among under-40s due to social and economic factors.
Billede genereret af AI

Self-reported cognitive disabilities surge among young U.S. adults

Rapporteret af AI Billede genereret af AI Faktatjekket

A peer-reviewed Neurology study finds a sharp rise in self-reported cognitive difficulties among U.S. adults from 2013 to 2023, with rates nearly doubling in people under 40 and the steepest increases among lower-income and less-educated groups. Authors point to social and economic factors and call for further study.

Scientists identify new dementia affecting millions of elderly

A recently recognized form of dementia, known as LATE, is reshaping understanding of cognitive decline in the elderly, with rising diagnoses and guidelines for doctors published this year. It is estimated to affect about one-third of people aged 85 or older and 10% of those aged 65 or older, often mistaken for Alzheimer's. Experts emphasize the need for a broader range of treatments for this condition.

Alzheimer's drug trials adopt cancer's multi-target approach

Rapporteret af AI

Alzheimer's trials are shifting to a multi-target approach inspired by cancer research, even after failures with Novo Nordisk's semaglutide. Only two drugs, Eli Lilly's Kisunla and Eisai and Biogen's Leqembi, are widely approved to slow progression. This evolution treats the brain-wasting disease as a complex system, seeking new ways to halt it amid its global impact.

Asia

Digital biomarkers can change dementia tracking: IISc professor

Europa

New test detects Alzheimer's with a finger prick

Europa

500.000 svenskere får sundheds- og livsstilsundersøgelse

Study finds risky drugs still prescribed to millions with dementia

A new study reveals that despite guidelines, about one in four Medicare beneficiaries with dementia continue to receive brain-altering medications linked to falls and confusion. Prescribing rates have declined overall from 20% to 16% between 2013 and 2021, but those with cognitive impairment face higher risks. Researchers highlight the need for better documentation and alternatives to improve care safety.

Borås svarer på kritik af mad i ældreplejen

Rapporteret af AI

Ældre- og socialforsikringsminister Anna Tenje (M) har kritiseret Borås for at skære ned på mad til ældre, mens de investerer i zoologisk have. Kommunalrådsleder Ulf Olsson afviser anklagerne og fremhæver, at der ikke er sparet på madkvaliteten. Debatten opstod i en radiosending om stigende madpriser i ældreplejen.

Hidden brain signal predicts Alzheimer's years before diagnosis

Scientists at Brown University have identified a subtle brain activity pattern that can forecast Alzheimer's disease in people with mild cognitive impairment up to two and a half years in advance. Using magnetoencephalography and a custom analysis tool, the researchers detected changes in neuronal electrical signals linked to memory processing. This noninvasive approach offers a potential new biomarker for early detection.

Chronic kidney disease now affects 788 million people worldwide, study finds

Rapporteret af AI Faktatjekket

A Lancet analysis estimates that nearly 800 million adults were living with chronic kidney disease in 2023—up from 378 million in 1990—with the illness now ranking ninth among global causes of death. Researchers urge earlier detection and wider access to proven treatments.

søndag d. 1. februar 2026, 15.59

U.S. midlife health declines sharply compared to other nations

tirsdag d. 27. januar 2026, 17.07

Study finds obesity and high blood pressure directly cause dementia

torsdag d. 22. januar 2026, 05.47

Super agers have genetic advantages against Alzheimer's risk

fredag d. 16. januar 2026, 00.50

Post-meal blood sugar spikes may increase Alzheimer’s risk

onsdag d. 14. januar 2026, 13.39

Massive study links accelerating memory loss to widespread brain changes

lørdag d. 10. januar 2026, 17.20

Study shows young blood slows Alzheimer's in mice

onsdag d. 31. december 2025, 02.28

Proposal for new system to support solitary elderly in Japan

onsdag d. 10. december 2025, 02.10

Obesity linked to faster rise in Alzheimer’s blood biomarkers, study finds

lørdag d. 6. december 2025, 00.34

Kidney problems may skew Alzheimer’s blood test results, study suggests

mandag d. 3. november 2025, 20.46

Alzheimer’s disrupts circadian rhythms in brain cells, mouse study finds

 

 

 

Dette websted bruger cookies

Vi bruger cookies til analyse for at forbedre vores side. Læs vores privatlivspolitik for mere information.
Afvis